Evidence of quality of life for hospitalised patients with COVID-19: a scoping review

Webb, Edward J. D., Howdon, Daniel, King, Natalie, Carrol, Enitan D., Euden, Joanne ORCID: https://orcid.org/0000-0002-2844-6878, Howard, Philip, Pallmann, Philip ORCID: https://orcid.org/0000-0001-8274-9696, Llewelyn, Martin, Thomas-Jones, Emma ORCID: https://orcid.org/0000-0001-7716-2786, Shinkins, Bethany and Sandoe, Jonathan 2024. Evidence of quality of life for hospitalised patients with COVID-19: a scoping review. Health Technology Assessment 10.3310/ATPR4281

Full text not available from this repository.

Abstract

Background Information on the quality of life of people hospitalised with COVID-19 is important, both in assessing the burden of disease and the cost-effectiveness of treatments. However, there were potential barriers to collecting such evidence. Objective To review the existing evidence on quality of life for people hospitalised with COVID-19, with a focus on the amount of evidence available and methods used. Design A scoping review with systematic searches. Results A total of 35 papers were selected for data extraction. The most common study type was economic evaluation (N = 13), followed by cross-sectional (N = 10). All economic evaluations used published utility values for other conditions to represent COVID-19 inpatients’ quality of life. The most popular quality-of-life survey measure was the Pittsburgh Sleep Quality Index (N = 8). There were 12 studies that used a mental health-related survey and 12 that used a sleep-related survey. Five studies used EQ-5D, but only one collected responses from people in the acute phase of COVID-19. Studies reported a negative impact on quality of life for people hospitalised with COVID-19, although many studies did not include a formal comparison group. Limitations Although it used systematic searches, this was not a full systematic review. Conclusion Quality-of-life data were collected from people hospitalised with COVID-19 from relatively early in the pandemic. However, there was a lack of consensus as to what survey measures to use, and few studies used generic health measures. Economic evaluations for COVID-19 treatments did not use utilities collected from people with COVID-19. In future health crises, researchers should be vigilant for opportunities to collect quality-of-life data from hospitalised patients but should try to co-ordinate as well as ensuring generic health measures are used more.

Item Type:	Article
Date Type:	Published Online
Status:	In Press
Schools:	Medicine Centre for Trials Research (CNTRR)
Publisher:	NIHR Journals Library
ISSN:	1366-5278
Date of Acceptance:	2 November 2023
Last Modified:	19 Jun 2024 13:07
URI:	https://orca.cardiff.ac.uk/id/eprint/165225

Actions (repository staff only)

Edit Item